Back to results
US 2010/0074906 A1Published application
Antibodies Specific for Varicella Zoster Virus
AssigneeRibovax Biotechnologies S.A.
InventorsRoberto Burioni, Massimo Clementi
Life of this patent
Estimating the term…
Abstract
The present invention provides novel antibody sequences that bind Varicella Zoster Virus (VZV) and neutralize VZV infection. The novel sequences can be used for the medical management of VZV infection, in particular for detecting the virus or for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of VZV infection.
Claims18
A protein comprising a sequence having at least 90% identity with SEQ ID NO.:
- 5.
(canceled)
(canceled)
Dependencies are inferred from the claim text.